Assessment of Safety and Satisfaction Toward COVID-19 Vaccines.

NCT ID: NCT05857176

Last Updated: 2023-05-23

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 508 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2021-12-15
• Study Completion Date: 2022-02-10

Brief Summary

This is a cross-sectional, web-based online survey done with the use of a Google Form-questionnaire to gather information from the general public regarding their knowledge, satisfaction, and tolerability about the COVID-19 vaccine.

Detailed Description

• A cross-sectional study was conducted. The subjects participating in the study are residents in Egypt.
• An online questionnaire, designed on Google Forms, was written in Arabic language and delivered to participants via social media (primarily Facebook, WhatsApp and Linkedin).
• The questionnaire comprised two categories of inquiries. The first is demographic data of the subject. The second is questions about COVID-19 vaccine-related data, such as whether had taken the vaccine or not, the type of vaccine administered, side effects encountered from the vaccine , if got enough information regarding the vaccine and where obtain the vaccine information from and if reluctant to taking the vaccine and the reasons for hesitancy. All participants were permitted to terminate the survey at any time of the study.

Conditions

COVID-19 Vaccine Adverse Reaction

Study Design

• Observational Model Type: OTHER
• Study Time Perspective: CROSS_SECTIONAL

Interventions

COVID-19 Vaccine questionnaire

An online questionnaire, designed on Google Forms, was written in Arabic language and delivered to participants via social media (primarily Facebook, WhatsApp and Linkedin).

Intervention Type: OTHER

Other Intervention Names

Google form questionnaire

Eligibility Criteria

Inclusion Criteria

• all adults (age ≥ 18 years) complete the questionnaire were considered eligible to participate in the survey.

Exclusion Criteria

• Incomplete questionnaires were excluded from the final analysis.

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 75 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Alexandria University

OTHER

Sponsor Role: collaborator

Damanhour University

OTHER

Sponsor Role: lead

Responsible Party

Rehab Werida

Principal Investigator

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Rehab H Werida, Ass. Prof.

Role: PRINCIPAL_INVESTIGATOR

Damanhour University

Locations

Rehab Hussein Werida

Damanhūr, Elbehairah, Egypt

Countries

Egypt

References

Malik A, Malik J, Ishaq U. Acceptance of COVID-19 vaccine in Pakistan among health care workers. PLoS One. 2021 Sep 15;16(9):e0257237. doi: 10.1371/journal.pone.0257237. eCollection 2021.

Reference Type: BACKGROUND

PMID: 34525110 (View on PubMed)

Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021 Feb;27(2):225-228. doi: 10.1038/s41591-020-1124-9. Epub 2020 Oct 20.

Reference Type: BACKGROUND

PMID: 33082575 (View on PubMed)

Other Identifiers

COVID-19 vaccines Perception

Identifier Type: -

Identifier Source: org_study_id